The MCPyV-ST and LT have an established role in the pathogenesis of MCC, counteracting against tumor-suppressing pathways, such as RB and P53, dysregulating their activity and affecting the cell cycle, thus leading to tumor growth. This evidence concerns the gene RB1 and Merkel cell skin cancer.